WallStreetZenWallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for JNJ

Based on 11 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$161.00-3.43%
Avg Forecast
$183.82+10.26%
Max Forecast
$205.00+22.96%

Should I buy or sell JNJ stock?

Based on 11 analysts offering ratings for Johnson & Johnson.
Buy
Strong Buy
2 analysts 18.18%
Buy
3 analysts 27.27%
Hold
6 analysts 54.55%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their JNJ stock forecasts and price targets.

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 17%
84
HoldMaintains$173.00+3.77%2022-09-12
UBS
Bottom 27%
27
HoldMaintains$180.00+7.97%2022-07-21Find out why
SVB Leerink
Top 13%
88
BuyMaintains$194.00+16.36%2022-07-20Find out why
Atlantic Equities
Bottom 30%
30
HoldMaintains$165.00-1.03%2022-07-20
Raymond James
Bottom 4%
4
BuyMaintains$192.00+15.16%2022-07-20Find out why
Citigroup
Top 8%
93
Strong BuyMaintains$201.00+20.56%2022-07-20Find out why
Wells Fargo
Top 19%
82
Strong BuyMaintains$195.00+16.96%2022-07-13Find out why
Credit Suisse
Bottom 6%
6
BuyMaintains$205.00+22.96%2022-04-20
Anonymous
Goldman Sachs
HoldMaintains$181.00+8.57%2022-04-12
Morgan Stanley
Bottom 2%
2
HoldMaintains$173.00+3.77%2022-04-06

1 of 2

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
39.53%
Industry
91.67%
Market
118.57%
JNJ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
16.98%
Industry
17.76%
JNJ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.70+53.08%
Avg 2 year Forecast
$10.51+50.36%
Avg 3 year Forecast
$11.24+60.8%
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$95.1B-0.47%
Avg 2 year Forecast
$98.9B+3.52%
Avg 3 year Forecast
$102.4B+7.1%
JNJ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.16%
Industry
13.64%
Market
16.42%
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
2.34%
Industry
0.92%
Market
8.46%
JNJ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JNJ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JNJ vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
JNJ$166.72$183.82+10.26%Buy
LLY$311.46$333.07+6.94%Strong Buy
ABBV$143.06$161.69+13.02%Buy
PFE$44.08$56.17+27.42%Buy
MRK$86.78$99.31+14.44%Buy
View Top General Drug Manufacturer Stocks

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: JNJ) stock is to Buy JNJ stock.

Out of 11 analysts, 2 (18.18%) are recommending JNJ as a Strong Buy, 3 (27.27%) are recommending JNJ as a Buy, 6 (54.55%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

If you're new to stock investing, here's how to buy Johnson & Johnson stock.

What is JNJ's earnings growth forecast for 2022-2024?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.16% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 13.64%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Johnson & Johnson's earnings in 2022 is $18,366,000,000.On average, 1 Wall Street analyst forecast JNJ's earnings for 2022 to be $28,132,224,877, with the lowest JNJ earnings forecast at $28,000,765,882, and the highest JNJ earnings forecast at $28,263,683,871. On average, 10 Wall Street analysts forecast JNJ's earnings for 2023 to be $27,632,680,696, with the lowest JNJ earnings forecast at $26,843,926,728, and the highest JNJ earnings forecast at $28,447,726,464.

In 2024, JNJ is forecast to generate $29,551,982,020 in earnings, with the lowest earnings forecast at $29,157,605,036 and the highest earnings forecast at $30,156,693,396.

What is JNJ's revenue growth forecast for 2022-2024?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 2.34% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 0.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Johnson & Johnson's revenue in 2022 is $95,588,000,000.On average, 6 Wall Street analysts forecast JNJ's revenue for 2022 to be $250,124,810,282,994, with the lowest JNJ revenue forecast at $249,012,257,035,345, and the highest JNJ revenue forecast at $250,810,616,083,525. On average, 6 Wall Street analysts forecast JNJ's revenue for 2023 to be $260,156,417,251,387, with the lowest JNJ revenue forecast at $259,026,803,255,400, and the highest JNJ revenue forecast at $262,258,407,139,741.

In 2024, JNJ is forecast to generate $269,167,878,757,902 in revenue, with the lowest revenue forecast at $265,870,558,522,085 and the highest revenue forecast at $272,488,204,317,800.

What is JNJ's forecast return on assets (ROA) for 2022-2025?

(NYSE: JNJ) forecast ROA is 16.98%, which is lower than the forecast US Drug Manufacturers - General industry average of 17.76%.

What is JNJ's Price Target?

According to 11 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $183.82, with the highest JNJ stock price forecast at $205.00 and the lowest JNJ stock price forecast at $161.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could reach $183.82 by Sep 12, 2023. The average Johnson & Johnson stock price prediction forecasts a potential upside of 10.26% from the current JNJ share price of $166.72.

What is JNJ's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.99. On average, analysts forecast that JNJ's EPS will be $10.70 for 2022, with the lowest EPS forecast at $10.65, and the highest EPS forecast at $10.75. On average, analysts forecast that JNJ's EPS will be $10.51 for 2023, with the lowest EPS forecast at $10.21, and the highest EPS forecast at $10.82. In 2024, JNJ's EPS is forecast to hit $11.24 (min: $11.09, max: $11.47).

What is JNJ's forecast return on equity (ROE) for 2022-2025?

(NYSE: JNJ) forecast ROE is 39.53%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.